查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1712509

全球组织水平植入物市场 - 2025 年至 2033 年

Global Tissue Level Implant Market - 2025-2033
出版日期: | 出版商: DataM Intelligence | 英文 176 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

2024 年全球组织级植入物市场规模达到 94.2 亿美元，预计到 2033 年将达到 163.8 亿美元，在 2025-2033 年预测期内的复合年增长率为 6.9%。

组织级植体是一种特殊类型的牙植体，其特点是其独特的设计，其中植体和基台之间的界面位于骨水平上方，直接与牙龈组织接触。这种设计对于癒合过程、病患照护和植入物的整体效果具有若干重要意义。

老年人口的增加和牙科疾病负担的增加以及技术进步预计将推动市场成长。随着年龄的增长，人们更容易因蛀牙、牙龈疾病和磨损等因素而失去牙齿。老年人群经常将植牙视为恢復口腔功能和美观的长期解决方案，这增加了对组织级植牙的需求。

市场动态：

驾驶员和约束装置

牙科植体需求不断增长

老年人口的增加和牙科疾病负担的增加预计将推动市场成长。随着年龄的增长，人们更容易因蛀牙、牙龈疾病和磨损等因素而失去牙齿。老年人群经常将植牙视为恢復口腔功能和美观的长期解决方案，这增加了对组织级植牙的需求。

例如，根据南加州大学赫尔曼·奥斯特罗牙科学院2024年的报告，估计65岁以上的成年人中约有5%是无牙的。此外，根据世界卫生组织2023年的报告，估计口腔疾病影响近35亿人。牙科疾病的增加增加了对组织级植入物的需求并推动了市场成长。

此外，合作伙伴关係、协作和产品发布等主要参与者的策略将推动这一市场的成长。例如，2022 年 11 月，一家名为 Prayasta 的新创公司与印度科学研究所 (IISc) 合作开发了世界上第一台用于植入级硅胶的 3D 列印机，名为 Silimac。这项创新技术在印度理工学院生物系统科学与工程中心 (BSSE) 亮相，旨在在医院环境中直接 3D 列印个人化硅胶植入物。

植入物成本高昂

组织级植入物成本高昂，严重限制了全球市场的发展，限制了患者的可近性，也为医疗保健提供者带来了挑战。组织级植入物需要高品质的生物相容性材料，例如钛、氧化锆或高级聚合物，这些材料成本昂贵。精密製造和消毒过程增加了整体成本。植入技术涉及大量的研发，以确保安全性、耐用性和与人体组织的兼容性。因此，上述因素可能会限制全球组织级植入物市场的潜在成长。

目录

第一章：市场介绍和范围

  • 报告目标
  • 报告范围和定义
  • 报告范围

第二章：高阶主管见解与关键要点

  • 市场亮点和战略要点
  • 主要趋势和未来预测
  • 按类型分类的程式码片段
  • 材料片段
  • 最终用户的程式码片段
  • 按地区分类的片段

第三章：动态

  • 影响因素
    • 驱动程式
      • 牙科植体需求不断增长
      • 技术进步
    • 限制
      • 植入物成本高昂
      • 与组织植入相关的困难
    • 机会
      • 新兴市场的扩张
    • 影响分析

第四章：战略洞察与产业展望

  • 市场领导者和先驱者
    • 新兴先锋和杰出参与者
    • 拥有最大销售品牌的既定领导者
    • 拥有成熟产品的市场领导者
  • CXO 观点
  • 最新进展与突破
  • 监管和报销情况
    • 北美洲
    • 欧洲
    • 亚太地区
    • 南美洲
    • 中东和非洲
  • 波特五力分析
  • 供应链分析
  • 专利分析
  • SWOT分析
  • 未满足的需求和差距
  • 市场进入和扩张的推荐策略
  • 情境分析：最佳情况、基本情况和最坏情况预测
  • 定价分析和价格动态
  • 关键意见领袖

第五章：组织级植入物市场（按类型）

  • 心血管植入物
  • 牙种植体
  • 乳房植入物
  • 脸部植入
  • 骨科植入物
  • 其他的

第六章：组织级植入物市场（依材料）

  • 钛
  • 氧化锆
  • 钴铬合金
  • 聚醚醚酮
  • 聚丙烯
  • 其他的

第七章：组织级植入物市场（依最终使用者）

  • 医院和诊所
  • 牙医诊所
  • 门诊手术中心
  • 其他的

第八章：组织级植入物市场，依区域市场分析与成长机会

  • 北美洲
    • 我们
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 西班牙
    • 义大利
    • 欧洲其他地区
  • 南美洲
    • 巴西
    • 阿根廷
    • 南美洲其他地区
  • 亚太
    • 中国
    • 印度
    • 日本
    • 韩国
    • 亚太其他地区
  • 中东和非洲

第九章：竞争格局与市场定位

  • 竞争概况和主要市场参与者
  • 市占率分析与定位矩阵
  • 策略伙伴关係、併购
  • 产品组合和创新的关键发展
  • 公司基准化分析

第十章：公司简介

  • Institut Straumann AG
    • 公司概况
    • 产品组合
      • 产品描述
      • 产品关键绩效指标 (KPI)
      • 历史和预测产品销售
      • 产品销售量
    • 财务概览
      • 公司收入
      • 地区收入份额
      • 收入预测
    • 关键进展
      • 併购
      • 关键产品开发活动
      • 监管部门批准等
    • SWOT分析
  • Nobel Biocare Services AG
  • Dentsply Sirona
  • Zimmer Biomet
  • Biotech Dental
  • BioHorizons
  • TBR Dental
  • Hiossen Implant Canada INC.
  • Southern Implant
  • Implant Direct

第 11 章：假设与研究方法

  • 资料收集方法
  • 数据三角测量
  • 预测技术
  • 数据验证和确认

第 12 章：附录

简介目录
Product Code: MD4253

The global tissue-level implant market reached US$ 9.42 billion in 2024 and is expected to reach US$ 16.38 billion by 2033, growing at a CAGR of 6.9 % during the forecast period of 2025-2033.

Tissue-level implants are a specialized type of dental implant characterized by their unique design, where the interface between the implant and the abutment is positioned above the bone level, directly in contact with the gum tissue. This design has several important implications for the healing process, patient care, and overall effectiveness of the implant.

The increasing geriatric population and the increasing burden of dental diseases, Rising geriatric population and burden of dental diseases, and technological advancements are expected to drive the market growth. People are more likely to lose teeth as they become older due to factors like decay, gum disease, and wear over time. The senior population frequently considers dental implants as a long-term solution for restoring oral function and aesthetics, increasing demand for tissue-level implants.

Market Dynamics: Drivers & Restraints

Increasing Demand for Dental Implants

The increasing geriatric population and the increasing burden of dental diseases are expected to drive the market growth. People are more likely to lose teeth as they become older due to factors like decay, gum disease, and wear over time. The senior population frequently considers dental implants as a long-term solution for restoring oral function and aesthetics, increasing demand for tissue-level implants.

For instance, according to the report by the Herman Ostrow School of Dentistry of USC in 2024, it is estimated that around 5% of adults older than 65 years are edentulous. Additionally, according to the report by the World Health Organization in 2023, it is estimated that oral diseases affect nearly 3.5 billion people. The increasing number of dental diseases increases demand for tissue-level implants and drives market growth.

Furthermore, key players' strategies such as partnerships & collaborations, and product launches would drive this market growth. For instance, in November 2022, a startup named Prayasta, in collaboration with the Indian Institute of Science (IISc), developed the world's first 3D printer for implant-grade silicone, named Silimac. This innovative technology was unveiled at the IISc's Centre for BioSystems Science and Engineering (BSSE) and is designed to directly 3D print personalized silicone implants within a hospital setting.

High Costs of Implants

The high cost of tissue-level implants is a significant restraint in the global market, limiting accessibility for patients and creating challenges for healthcare providers. Tissue-level implants require high-quality biocompatible materials such as titanium, zirconia, or advanced polymers, which are costly. The precision manufacturing and sterilization processes add to the overall expense. Implant technology involves extensive R&D to ensure safety, durability, and compatibility with human tissues. Thus, the above factors could be limiting the global tissue-level implant market's potential growth.

Segment Analysis

The global tissue-level implant market is segmented based on type, material, end-user, and region.

Type:

The dental implant segment in type is expected to dominate the global tissue-level implant market with the highest market share

Dental implants are an artificial solution for tooth replacement, designed to provide a permanent and functional alternative to traditional prosthetics such as dentures and bridges. The rise in dental diseases, particularly periodontal disease and dental caries, is a significant driver of demand for dental implants. This demand is largely fueled by the consequences of these conditions, which often lead to tooth loss and the subsequent need for effective replacement solutions.

According to WHO data in March 2023, the prevalence of dental diseases, particularly dental caries and periodontal disease, is a significant public health concern globally. An estimated 2 billion people suffer from caries of permanent teeth, and 514 million children are affected by caries of primary teeth. This widespread occurrence is exacerbated by factors such as urbanization and changing living conditions, which contribute to the increasing prevalence of these oral diseases.

Innovations in materials, technology, and surgical techniques have enhanced the appeal of dental implants among both patients and practitioners. As advancements continue to evolve within this field, dental implants are increasingly recognized as the gold standard for tooth replacement solutions, offering lasting benefits that align with modern expectations for oral health and aesthetics.

Furthermore, key players in the industry product launchers that would drive this market growth. For instance, Nobel Biocare introduced two advanced surfaces for dental implants: Xeal for abutments and TiUltra for implants. These surfaces leverage Nobel Biocare's extensive expertise in anodization technology, which is crucial for optimizing tissue integration at every level of the implant system, from the abutment to the apex.

For instance, in March 2022, Bredent Medical launched a new generation of whiteSKY zirconia implants, enhancing its existing line of ceramic dental implants. This updated implant system is designed to meet the growing demand for aesthetic and biocompatible dental solutions, particularly for patients who prefer metal-free options. These factors have solidified the segment's position in the global tissue-level implant market.

Geographical Analysis

North America is expected to hold a significant position in the global tissue-level implant market with the highest market share

There is an increasing number of periodontal diseases in the North America region. Gum (periodontal) disease is a broad term for gingivitis and periodontitis. These conditions involve infection and inflammation of the tissues (e.g., gum and bone) around the teeth.

For instance, according to the World Health Organization (WHO), the most common oral health conditions include cavities, gum disease, tooth loss, and oral cancer. About 90% of U.S. adults 20 years and older have experienced at least one cavity. Nearly half (42%) of U.S. adults have periodontal (gum) disease. Thus, the above factors are expected to hold the region in the dominant position during the forecast period.

Continuous innovations in implant materials (like titanium and zirconia), design, and surgical techniques have improved the success rates of tissue-level implants. Enhanced biocompatibility and osseointegration properties make these implants more appealing to both patients and healthcare providers. Moreover, in this region, a majority of key players' presence, well-advanced healthcare infrastructure, government initiatives & regulatory support, technological advancements, & investments, and product launches & approvals would propel this market growth.

For instance, in February 2024, American Academy of Orthopaedic Surgeons (AAOS) Annual Meeting, Anika Therapeutics launched the Integrity Implant System and the RevoMotion Reverse Shoulder Arthroplasty System, along with other key regenerative products. This event is a significant gathering for orthopedic professionals, showcasing the latest advancements in orthopedic surgery and rehabilitation.

Similarly, in June 2023, the FDA approved the SNUCONE Co., Ltd., developed the SNUCONE Tissue Level Implant System, which is designed for use in dental applications, specifically for partially or fully edentulous (toothless) mandibles (lower jaw) and maxillae (upper jaw). The system is intended to support single or multiple dental restorations, making it a versatile option for patients requiring dental implants. Thus, the above factors are consolidating the region's position as a dominant force in the global tissue-level implant market.

Competitive Landscape

The major global players in the tissue-level implant market include Institut Straumann AG, Nobel Biocare Services AG, Dentsply Sirona, Zimmer Biomet, Biotech Dental, BioHorizons, TBR Dental, Hiossen Implant Canada INC., Southern Implant, and Implant Direct, among others.

Key Developments

  • In January 2023, MediNiche introduced Bone-Tite, the first dietary supplement specifically designed for dental implant patients. Bone-Tite aims to provide nutritional support before and after dental implant procedures, addressing the critical role that nutrition plays in the osseointegration process and the integration of the implant with the surrounding bone.

Why Purchase the Report?

  • Pipeline & Innovations: Reviews ongoing clinical trials and product pipelines and forecasts upcoming advancements in medical devices and pharmaceuticals.
  • Product Performance & Market Positioning: Analyzed product performance, market positioning, and growth potential to optimize strategies.
  • Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
  • Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
  • Market Updates & Industry Changes: This covers recent regulatory changes, new policies, and emerging technologies.
  • Competitive Strategies: Analyze competitor strategies, market share, and emerging players.
  • Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
  • Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
  • Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
  • Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
  • Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
  • Post-market Surveillance: Uses post-market data to enhance product safety and access.
  • Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global tissue-level implant market report delivers a detailed analysis with 62 key tables, more than 59 visually impactful figures, and 176 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2024

  • Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
  • Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
  • Technology & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
  • Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
  • Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
  • Supply Chain: Distribution and Supply Chain Managers.
  • Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
  • Academic & Research: Academic Institutions.

Table of Contents

1. Market Introduction and Scope

  • 1.1. Objectives of the Report
  • 1.2. Report Coverage & Definitions
  • 1.3. Report Scope

2. Executive Insights and Key Takeaways

  • 2.1. Market Highlights and Strategic Takeaways
  • 2.2. Key Trends and Future Projections
  • 2.3. Snippet by Type
  • 2.4. Snippet by Material
  • 2.5. Snippet by End-User
  • 2.6. Snippet by Region

3. Dynamics

  • 3.1. Impacting Factors
    • 3.1.1. Drivers
      • 3.1.1.1. Increasing Demand for Dental Implants
      • 3.1.1.2. Technological Advancements
    • 3.1.2. Restraints
      • 3.1.2.1. High Costs of Implants
      • 3.1.2.2. Difficulties Associated with Tissue Implants
    • 3.1.3. Opportunity
      • 3.1.3.1. Expansion in Emerging Markets
    • 3.1.4. Impact Analysis

4. Strategic Insights and Industry Outlook

  • 4.1. Market Leaders and Pioneers
    • 4.1.1. Emerging Pioneers and Prominent Players
    • 4.1.2. Established leaders with the largest-selling Brand
    • 4.1.3. Market leaders with established Product
  • 4.2. CXO Perspectives
  • 4.3. Latest Developments and Breakthroughs
  • 4.4. Regulatory and Reimbursement Landscape
    • 4.4.1. North America
    • 4.4.2. Europe
    • 4.4.3. Asia Pacific
    • 4.4.4. South America
    • 4.4.5. Middle East & Africa
  • 4.5. Porter's Five Forces Analysis
  • 4.6. Supply Chain Analysis
  • 4.7. Patent Analysis
  • 4.8. SWOT Analysis
  • 4.9. Unmet Needs and Gaps
  • 4.10. Recommended Strategies for Market Entry and Expansion
  • 4.11. Scenario Analysis: Best-Case, Base-Case, and Worst-Case Forecasts
  • 4.12. Pricing Analysis and Price Dynamics
  • 4.13. Key Opinion Leaders

5. Tissue Level Implant Market, By Type

  • 5.1. Introduction
    • 5.1.1. Analysis and Y-o-Y Growth Analysis (%), By Type
    • 5.1.2. Market Attractiveness Index By Type
  • 5.2. Cardiovascular Implants*
    • 5.2.1. Introduction
    • 5.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 5.3. Dental Implant
  • 5.4. Breast Implant
  • 5.5. Facial Implant
  • 5.6. Orthopaedic Implants
  • 5.7. Others

6. Tissue Level Implant Market, By Material

  • 6.1. Introduction
    • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
    • 6.1.2. Market Attractiveness Index By Material
  • 6.2. Titanium*
    • 6.2.1. Introduction
    • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 6.3. Zirconia
  • 6.4. Cobalt-Chromium Alloys
  • 6.5. Polyetheretherketone
  • 6.6. Polypropylene
  • 6.7. Others

7. Tissue Level Implant Market, By End-User

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 7.1.2. Market Attractiveness Index, By End-User
  • 7.2. Hospitals & Clinics*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Dental Clinics
  • 7.4. Ambulatory Surgical Centers
  • 7.5. Others

8. Tissue Level Implant Market, By Regional Market Analysis and Growth Opportunities

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 8.1.2. Market Attractiveness Index, By Region
  • 8.2. North America
    • 8.2.1. Introduction
    • 8.2.2. Key Region-Specific Dynamics
    • 8.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 8.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
    • 8.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 8.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 8.2.6.1. U.S.
      • 8.2.6.2. Canada
      • 8.2.6.3. Mexico
  • 8.3. Europe
    • 8.3.1. Introduction
    • 8.3.2. Key Region-Specific Dynamics
    • 8.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 8.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
    • 8.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 8.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 8.3.6.1. Germany
      • 8.3.6.2. U.K.
      • 8.3.6.3. France
      • 8.3.6.4. Spain
      • 8.3.6.5. Italy
      • 8.3.6.6. Rest of Europe
  • 8.4. South America
    • 8.4.1. Introduction
    • 8.4.2. Key Region-Specific Dynamics
    • 8.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 8.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
    • 8.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 8.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 8.4.6.1. Brazil
      • 8.4.6.2. Argentina
      • 8.4.6.3. Rest of South America
  • 8.5. Asia-Pacific
    • 8.5.1. Introduction
    • 8.5.2. Key Region-Specific Dynamics
    • 8.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 8.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
    • 8.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 8.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 8.5.6.1. China
      • 8.5.6.2. India
      • 8.5.6.3. Japan
      • 8.5.6.4. South Korea
      • 8.5.6.5. Rest of Asia-Pacific
  • 8.6. Middle East and Africa
    • 8.6.1. Introduction
    • 8.6.2. Key Region-Specific Dynamics
    • 8.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 8.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
    • 8.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

9. Competitive Landscape and Market Positioning

  • 9.1. Competitive Overview and Key Market Players
  • 9.2. Market Share Analysis and Positioning Matrix
  • 9.3. Strategic Partnerships, Mergers & Acquisitions
  • 9.4. Key Developments in Product Portfolios and Innovations
  • 9.5. Company Benchmarking

10. Company Profiles

  • 10.1. Institut Straumann AG*
    • 10.1.1. Company Overview
    • 10.1.2. Product Portfolio
      • 10.1.2.1. Product Description
      • 10.1.2.2. Product Key Performance Indicators (KPIs)
      • 10.1.2.3. Historic and Forecasted Product Sales
      • 10.1.2.4. Product Sales Volume
    • 10.1.3. Financial Overview
      • 10.1.3.1. Company Revenue
      • 10.1.3.2. Geographical Revenue Shares
      • 10.1.3.3. Revenue Forecasts
    • 10.1.4. Key Developments
      • 10.1.4.1. Mergers & Acquisitions
      • 10.1.4.2. Key Product Development Activities
      • 10.1.4.3. Regulatory Approvals, etc.
    • 10.1.5. SWOT Analysis
  • 10.2. Nobel Biocare Services AG
  • 10.3. Dentsply Sirona
  • 10.4. Zimmer Biomet
  • 10.5. Biotech Dental
  • 10.6. BioHorizons
  • 10.7. TBR Dental
  • 10.8. Hiossen Implant Canada INC.
  • 10.9. Southern Implant
  • 10.10. Implant Direct

LIST NOT EXHAUSTIVE

11. Assumptions and Research Methodology

  • 11.1. Data Collection Methods
  • 11.2. Data Triangulation
  • 11.3. Forecasting Techniques
  • 11.4. Data Verification and Validation

12. Appendix

  • 12.1. About Us and Services
  • 12.2. Contact Us